Hong Kong's pharmaceuticals/health care market should reach $1.35 billion by 2014
Growth of the pharmaceutical market in Hong Kong is expected to be steady over the medium term. The market should reach HK$10.56 billion ($1.35 billion) in value at consumer prices by 2014, up from the calculated HK$7.19billion in 2009, according to a new report from Business Monitor International.
This represents a compound annual growth rate (CAGR) of 7.99% in local currency terms, which will somewhat decrease to 7.06% over BMI’s longer, 10-year forecast period to 2019. A testament to its attractiveness, Hong Kong now occupies fifth place in the Asia Pacific Pharmaceuticals & Healthcare Business Environment Ratings (BER) matrix for first-quarter 2011, which ranks 17 key regional markets, says BMI.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Pharmaceutical
| Headless Content Management with Blaze